Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Today, we are highlighted in the Presences revue of the Grenoble CCI for this market authorization.
For more information, please click on the link Présences_CCI de Grenoble.
FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery. The FLUOBEAM® Imaging System becomes the first and unique system certified for this indication.
The FLUOBEAM® provides, earlier, real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands). The early detection of theses glands allows reduces postoperative hypocalcemia.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Fluoptics is proud to announce that the French Hospital Union for Sales (UniHA) has referenced the FLUOBEAM® Imaging System.
This trust is important for us and reinforce Fluoptics’ development in Europe and particularly in France.
FLUOPTICS© is proud to have been chosen to participate in a report published during the “Journal de la Santé” (France 5) on December 8th, 2015; on the fluorescence imaging profits with FLUOBEAM® in the case of liver surgery (liver cancer).
The FLUOPTICS©’s mission is to supply to surgeons real-time information to localize exactly the fluorescent marker during the surgery. Thanks to the use of innovative technologies, FLUOPTICS© is confronted with various health problems.
Earlier in June, Fluoptics has been pleased to receive the renowned international speakers in Paris to promote a share knowledge on latest fluorescence surgery techniques. Fluoptics would like to thank you all speakers for their great présentations.
The aim of the study was to compare 2 methods of the sentinel lymph node biopsy (SLNB) procedure in bladder cancer: we applied technetium radiocolloid (RadCol) detected by a gamma ray detection probe, and indocyanine green (ICG) detected by a near-infrared fluorescent (NIRF) camera.